| |
| |
|
| Insider
Information: |
Panzara Michael A. |
| Relationship: |
See Remarks |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
75,817 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$443,529 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
75,817 |
|
|
| Total
Value |
$443,529 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 51.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Wave Life Sciences Ltd. |
WVE |
See Remarks |
2022-02-16 |
75,817 |
2016-07-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WVE |
Wave Life Sciences Ltd. |
See Remarks |
• – – |
2022-02-16 |
4 |
S |
$2.31 |
$24,493 |
D/D |
(10,603) |
75,817 |
0 |
% |
|
| WVE |
Wave Life Sciences Ltd. |
See Remarks |
• – – |
2021-02-16 |
4 |
AS |
$10.57 |
$30,960 |
D/D |
(2,929) |
86,420 |
0 |
% |
|
| WVE |
Wave Life Sciences Ltd. |
See Remarks |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
89,349 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
AS |
$7.85 |
$23,401 |
D/D |
(2,981) |
39,349 |
0 |
% |
|
| WVE |
Wave Life Sciences Ltd. |
Chief Medical Officer |
• – – |
2019-07-05 |
4 |
AS |
$26.88 |
$82,368 |
D/D |
(3,058) |
42,330 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2019-03-11 |
4 |
AS |
$48.00 |
$336,000 |
D/D |
(7,000) |
45,388 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,388 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2019-02-19 |
4 |
AS |
$36.84 |
$67,674 |
D/D |
(1,837) |
37,388 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2018-02-16 |
4 |
AS |
$52.10 |
$26,623 |
D/D |
(511) |
39,225 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2018-02-15 |
4 |
AS |
$50.00 |
$937,500 |
D/D |
(18,750) |
39,736 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2018-02-15 |
4 |
OE |
$21.69 |
$406,688 |
D/D |
18,750 |
58,486 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2018-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
39,736 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2017-07-12 |
4 |
AS |
$16.67 |
$123,620 |
D/D |
(7,414) |
15,336 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Head of Neurology Franchise |
• – – |
2017-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,900 |
29,650 |
0 |
- |
|
| WVE |
Wave Life Sciences Ltd. |
Franchise Lead, Neurology |
• – – |
2016-07-11 |
4 |
A |
$0.00 |
$0 |
D/D |
22,750 |
22,750 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
